Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

NICE recommends Eli Lilly’s psoriatic arthritis drug

August 9, 2018 Research and Development, Sales and Marketing Eli Lilly, England, NICE, Wales, psoriatic arthritis

Eli Lilly have announced that the monoclonal antibody ixekizumab, has been recommended by NICE for use as a treatment option …
News

NICE recommends Pfizer’s Besponsa in rare leukaemia following review

August 9, 2018 Sales and Marketing NICE, Pfizer, leukaemia, pharma

Pfizer has revealed that NICE has finally decided to recommend its CD22-targeting monoclonal antibody Besponsa (inotuzumab ozogamicin) in the treatment …
News

Insys Therapeutics reaches $150m agreement to settle opioid marketing case

August 9, 2018 Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma

The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …
News
AstraZeneca

AstraZeneca to pay $110m to settle allegations of fraudulent marketing in Texas

August 8, 2018 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Texaas, US, pharma

AstraZeneca has backed down in a dispute with the State of Texas over allegations it had defrauded the state’s Medicaid …
News

GSK appoint HSBC director Iain Mackay as new CFO

August 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Iain Mckay, cfo, hsbc

British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …
Appointment
shutterstock_79370437

Ironwood returns US Zurampic rights to AstraZeneca, announces operational cuts

August 7, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Ironwood, Zurampic, gout, pharma

Ironwood Pharmaceuticals has revealed that it has taken the decision to hand the rights for gout therapy Zurampic (lesinurad) back …
News

Pain Therapeutics refocuses on Alzheimer’s after FDA turns down abuse-deterrent opioid painkiller

August 7, 2018 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Remoxy, opioid crisis, opioids, pain therapeutics, pharma

The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …
News
28246711066_52e38bc591_z

MHRA sets out Brexit implementation period plan

August 7, 2018 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, MHRA, UK, brexit, implentation period

The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …
News
omeros_logo_home_resized

Sanofi’s Dr Eckhard Leifke joins Seattle-based biotech Omeros

August 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Eckhard Leifke, Omeros, Sanofi, Seattle, Takeda

The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical …
Appointment
800px-t_lymphocyte_16760076824

Regeneron Pharma and Bluebird bio announce immune cell collaboration

August 6, 2018 Sales and Marketing Cancer, Regeneron, Shares, bluebird, collaboration, t cells, t-cells

Regeneron Pharmaceuticals have announced that they will collaborate with the Massachusetts-based gene therapy specialist Bluebird bio in an effort to …
News
diversity_graphic

Enough talk: Action is required to achieve parity in biotech

August 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Women in pharma, diversity, feature, pharma, women

Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …
Feature
jazz_pharma

Jazz Pharmaceuticals to expand Irish workforce across Dublin, Athlone sites

August 6, 2018 Manufacturing and Production, Sales and Marketing Dublin, Ireland, jazz pharmaceuticals, pharma

Jazz Pharmaceuticals has announced its intention to expand its staff numbers at two of its bases in its home country …
News

Pfizer to consider stockpiling medicines in preperation for no-deal Brexit

August 6, 2018 Sales and Marketing EU, MSD, Pfizer, Sanofi, brexit, stockpiling

Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …
News
armind_madan

England’s top GP resigns over imflammatory online comments

August 6, 2018 Medical Communications, Research and Development, Sales and Marketing Dr Armind Madan, England, GP, pharma

England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …
News
16193381408_003eb2fdc9_z1

Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest

August 6, 2018 Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby

The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025